Status:
COMPLETED
Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer
Lead Sponsor:
SCRI Development Innovations, LLC
Collaborating Sponsors:
Eli Lilly and Company
GlaxoSmithKline
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the effectiveness of the three-drug combination paclitaxel, carboplatin, and gemcitabine to the two-drug combination gemcitabine and vinorelbine in patients wit...
Detailed Description
Upon determination of eligibility, patients will be randomly assigned to one of two treatment arms: * Paclitaxel + Carboplatin + Gemcitabine * Gemcitabine + Vinorelbine For ever 2 patients treated, ...
Eligibility Criteria
Inclusion
- To be included in this study, you must meet the following criteria:
- Non-small cell bronchogenic carcinoma
- Newly diagnosed unresectable stage IIIB or stage IV disease
- Patients with stage IIIB disease should be ineligible for combined therapy
- Patients must have measurable lesion definable by X-ray or CT scan.
- No prior antineoplastic chemotherapy for lung cancer prior to study entry
- Age \> 18 years
- Able to perform activities of daily living with minimal assistance
- Adequate bone marrow, liver and kidney function
- Written informed consent must be obtained prior to study entry
- Patients must be available for treatment and followup.
Exclusion
- You cannot participate in this study if any of the following apply to you:
- Female patient pregnant or lactating
- History of heart disease
- Serious active infection at the time of treatment
- Other serious underlying medical condition
- Brain metastasis
- Patients without measurable disease
- Uncontrolled diabetes mellitus defined as random blood sugar \> 250mg/dL
- Dementia or significantly altered mental status
- Significant peripheral neuropathy by history or physical examination.
- Please note: There are additional inclusion/exclusion criteria. The study center will determine if you meet all of the criteria. If you do not qualify for the trial, study personnel will explain the reasons. If you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
September 1 2007
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00193362
Start Date
June 1 2004
End Date
September 1 2007
Last Update
July 28 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.